Skip to content

The Evaluation of External Thermomechanical Stimulation for Pain Reduction in Patients Undergoing Nail Injection

The Evaluation of External Thermomechanical Stimulation for Pain Reduction in Patients Undergoing Nail Injection

Status
Withdrawn
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04422795
Enrollment
0
Registered
2020-06-09
Start date
2024-02-29
Completion date
2025-07-31
Last updated
2023-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nail Diseases

Keywords

Nails, Thermomechanical stimulation, Intralesional injection

Brief summary

The purpose of this study is to assess the efficacy and safety of a thermomechanical device delivering vibration and cold stimuli in lowering pain during intramatricial nail injections

Interventions

DEVICEExternal thermomechanical device delivering cold and vibration stimuli

the thermomechanical device will be placed on the digit 2 cm proximally to the injection site with the ice wings frozen and the vibration mechanism switched on, delivering vibration and cold stimuli to the area for 30 seconds before the intramatricial injection and until needle withdrawal

DEVICEExternal thermomechanical device without delivering cold and vibration stimuli

the thermomechanical device will be placed on the digit 2 cm proximally to the injection site with the ice wings at unfrozen and the vibration mechanism switched off, for 30 seconds before the intramatricial injection and until needle withdrawal

DRUGEthyl chloride skin refrigerant spray

Ethyl chloride skin refrigerant spray is applied to the area of injection for 3 seconds immediately before needle insertion

Sponsors

Weill Medical College of Cornell University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Men and women aged 18 years or older * Must understand and voluntarily sign an informed consent form * All patients undergoing intramatricial nail injections at the Weill Cornell Medicine (WCM) Department of Dermatology * Willingness to participate in the study

Exclusion criteria

* Inability of the patient to provide written informed consent for any reason * Failure to have nail injection performed * Likely inability to comply with the study protocol or cooperate fully with the research team

Design outcomes

Primary

MeasureTime frameDescription
The level of pain and change in pain between each time point will be assessed using the Wong-Baker FACES scale with use of thermomechanical device delivering stimuli, without delivering stimuli, and with use of ethyl chloride skin refrigerant spray.prior to treatment, immediately after the needle insertion, during infiltration and 5 seconds after needle extractionPain will be self-reported, using the Wong-Baker FACES (0-10, with 0 representing absence of pain and 10 unbearable pain). Participants will be questioned about their level of pain in their nail prior to treatment, immediately after the needle insertion, during infiltration, and 5 seconds after needle extraction

Secondary

MeasureTime frameDescription
Number of participants with at least one adverse eventPatients will be followed for 3 days following their nail injectionAdverse events will only include those that are determined to be related to the study device

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026